Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
18 Feb, 2022
Team Health Inc. has completed an amend-and-extend of its covenant-lite term loan B that pushes out the maturity of a portion of the TLB by three years to February 2027 from February 2024, according to sources. Pricing on the extended loan is tied to a ratings-based grid, with a spread of 475 basis points over the secured overnight financing rate if corporate ratings are at or better than B-/B3, with stable outlooks, from S&P Global Ratings and Moody's and 525 bps over Sofr if they are worse. There is a 1% Sofr floor and no credit spread adjustment. The extended loan was issued at an original issue discount of 99.5. Total size of the extended term loan is about $1.585 billion, and the nonextended tranche stands at roughly $1.18 billion. Extending lenders were eligible to participate in a partial debt paydown of up to $300 million in aggregate in connection with the transaction, rating agencies noted. Blackstone-backed Team Health provides healthcare-professional staffing and administrative services.
Terms:
| Borrower | Team Health Holdings Inc. |
| Issue | $1.585 billion extended term loan B |
| UoP | Amend-and-extend |
| Spread | Sofr+525 |
| Sofr floor | 1.00% |
| Issue price | 99.50 |
| Tenor | February 2027 |
| YTM | 6.52% |
| Four-year yield | 6.55% |
| Call protection | 101 soft call for 6 months |
| Corporate ratings | B-/Caa1/CCC+ |
| Facility ratings | B-/B3/B |
| Recovery ratings | 3 |
| Financial covenants | None |
| Arrangers | JPM |
| Admin agent | JPM |
| Px Talk | Sofr+450/1%/99.5 |
| Sponsor | Blackstone |
| Notes | Spread is Sofr+475 if corporate ratings are at or better than B-/B3, with stable outlooks, from S&P Global Ratings and Moody's and Sofr+525 if worse. No CSA. Nonextended term loan due February 2024 totals approximately $1.18 billion. |